These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 36305726)
1. Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape. Qiu Y; Hu X; Zeng X; Wang H Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(11):1569-1576. PubMed ID: 36305726 [TBL] [Abstract][Full Text] [Related]
2. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response. Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009 [TBL] [Abstract][Full Text] [Related]
3. Mapping combinatorial drug effects to DNA damage response kinase inhibitors. Zhang H; Kreis J; Schelhorn SE; Dahmen H; Grombacher T; Zühlsdorf M; Zenke FT; Guan Y Nat Commun; 2023 Dec; 14(1):8310. PubMed ID: 38097586 [TBL] [Abstract][Full Text] [Related]
4. Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions. Basourakos SP; Li L; Aparicio AM; Corn PG; Kim J; Thompson TC Curr Med Chem; 2017; 24(15):1586-1606. PubMed ID: 27978798 [TBL] [Abstract][Full Text] [Related]
5. Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control. Concannon K; Morris BB; Gay CM; Byers LA Mol Cell; 2023 Mar; 83(5):660-680. PubMed ID: 36669489 [TBL] [Abstract][Full Text] [Related]
7. Expression variations of DNA damage response genes ATM and ATR in blood cancer patients. Parvez A; Mahjabeen I; Mehmood A; Khan AU; Nisar A; Kayani MA Mol Genet Genomics; 2023 Sep; 298(5):1173-1183. PubMed ID: 37338595 [TBL] [Abstract][Full Text] [Related]
8. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3. Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y J Virol; 2019 May; 93(9):. PubMed ID: 30787154 [TBL] [Abstract][Full Text] [Related]
9. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma. Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345 [TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor. Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154 [TBL] [Abstract][Full Text] [Related]
11. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs. Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101 [TBL] [Abstract][Full Text] [Related]
12. The ATR inhibition by Elimusertib enhances the radiosensitivity of MDA-MB-231 triple negative breast cancer in vitro. Guney Eskiler G; Halis H; Hamarat KF; Derlioglu RR; Ugurlu BT; Haciefendi A Int J Radiat Biol; 2024; 100(5):715-723. PubMed ID: 38421209 [TBL] [Abstract][Full Text] [Related]
13. Biphasic Functional Interaction between the Adenovirus E4orf4 Protein and DNA-PK. Nebenzahl-Sharon K; Shalata H; Sharf R; Amer J; Khoury-Haddad H; Sohn SY; Ayoub N; Hearing P; Kleinberger T J Virol; 2019 May; 93(10):. PubMed ID: 30842317 [TBL] [Abstract][Full Text] [Related]
14. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy. Huang JL; Chang YT; Hong ZY; Lin CS Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658 [TBL] [Abstract][Full Text] [Related]
15. Rotavirus activates a noncanonical ATM-Chk2 branch of DNA damage response during infection to positively regulate viroplasm dynamics. Sarkar R; Patra U; Lo M; Mukherjee A; Biswas A; Chawla-Sarkar M Cell Microbiol; 2020 Mar; 22(3):e13149. PubMed ID: 31845505 [TBL] [Abstract][Full Text] [Related]
16. Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells. Takeuchi M; Tanikawa M; Nagasaka K; Oda K; Kawata Y; Oki S; Agapiti C; Sone K; Miyagawa Y; Hiraike H; Wada-Hiraike O; Kuramoto H; Ayabe T; Osuga Y; Fujii T Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31805725 [No Abstract] [Full Text] [Related]
17. An insight into the mechanism of DNA damage response in plants- role of SUPPRESSOR OF GAMMA RESPONSE 1: An overview. Mahapatra K; Roy S Mutat Res; 2020; 819-820():111689. PubMed ID: 32004947 [TBL] [Abstract][Full Text] [Related]
18. Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer. Alsubhi N; Middleton F; Abdel-Fatah TM; Stephens P; Doherty R; Arora A; Moseley PM; Chan SY; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Martin SG; Curtin NJ; Madhusudan S Mol Oncol; 2016 Feb; 10(2):213-23. PubMed ID: 26459098 [TBL] [Abstract][Full Text] [Related]
19. Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway. Chou WC; Hu LY; Hsiung CN; Shen CY Carcinogenesis; 2015 Aug; 36(8):832-40. PubMed ID: 26025911 [TBL] [Abstract][Full Text] [Related]
20. The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem? Sadoughi F; Mirsafaei L; Dana PM; Hallajzadeh J; Asemi Z; Mansournia MA; Montazer M; Hosseinpour M; Yousefi B DNA Repair (Amst); 2021 May; 101():103074. PubMed ID: 33640757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]